U
6621
vs
T
Taiwan Weighted Index
Over the past 12 months, Uni Pharma Co Ltd has underperformed Taiwan Weighted Index, delivering a return of -7% compared to Taiwan Weighted Index's +90% growth.
Stocks Performance
6621 vs Taiwan Weighted Index
Performance Gap
6621 vs Taiwan Weighted Index
Performance By Year
6621 vs Taiwan Weighted Index
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Uni Pharma Co Ltd
Glance View
Unipharma Co., Ltd. engages in the manufacturing, research and development of drugs and medical equipment. The company is headquartered in Taipei City, Taipei and currently employs 34 full-time employees. The company went IPO on 2017-08-18. The firm's main products include Onko-SureDR-70, for monitoring and marking after Colorectal cancer surgery;Cervi-M, using in detection of DNA methylation for Cervical cancer; EZ Detect, home use fecal occult blood test paper;RFA, cancer treatment medical equipment;Bain inj, a kind of morphine analgesics;Naloxone inj, antidote for morphine drugs overdose;Esmolol inj, ultrashort type B sympathetic nerve blockers;Fomepizole inj, a kind of alcoholic poisoning antidote;and Tambocor tab, a kind of arrhythmia treatment.
